|
|
| |
Curalogic is a publically listed biotechnology company re-establishing a development pipeline. Shares of the company are traded on the Copenhagen stock exchange. |
 |
www.curalogic.com |
|
|
|
|
|
Osteologix A/S is focused on the development of pharmaceuticals against bone and joint related diseases. The Company's lead compound belongs to a new class of pharmaceuticals having an ability to down-regulate bone resorption and up-regulate bone formation. The drug effects and side effects of the active ingredient has been extensively documented in large human efficacy trials totalling more than 7000 patients. Osteologix is currently in further clinical development with the lead candidate and holds a substantial clinical pipeline in the area. The company has their corporate office in Virginia, USA |
|
www.osteologix.com |
|
|
|
|
|
LifeCycle Pharma has a pipeline of late-stage development projects. Shares in the company are traded on the Copenhagen stock exchange. |
|
www.lifecyclepharma.com |
|
|
